FinanceCity
HealthcareNSE · BSE

Supriya Lifescience Limited

SUPRIYA · ISIN INE07RO01027

Share price

₹942 -1.42%

Market capitalisation

₹7579 CrClosed

Live from Yahoo Finance. Pulse animates during NSE market hours (9:15–15:30 IST, weekdays).

01 · Key metrics

Market cap

₹7579 Cr

Current price

₹942

-1.42% today

52W high

₹1,085

52W low

₹546

Stock P/E

36.25

P/B ratio

6.33

02 · Per share & returns

EPS (TTM)

₹25.98

Book value

₹149

ROE

19.06%

ROA

13.45%

Dividend yield

0.10%

Beta

0.64

03 · Financials (TTM)

By the numbers

Revenue

₹828 Cr

+50.20% YoY

EBITDA

₹294 Cr

Net profit

₹209 Cr

+46.70% YoY

Profit margin

25.26%

Operating margin

32.23%

Total debt

₹5.43 Cr

Total cash

₹78.87 Cr

Debt / equity

0.00x

Current ratio

4.40x

Payout ratio

3.85%

04 · Analyst view

Target price

₹940

Upside

-0.18%

Consensus

NONE

Analysts

2

05 · Shareholding pattern

Who owns SUPRIYA?

  • Promoters

    68.30%

    Founders & promoter group

  • Institutions

    4.68%

    FII + DII

  • Public

    27.02%

    Retail & non-institutional

As of 31 Mar 2026 · Source: NSE corporate filings

06 · Registration & listing

On the record

Symbol
SUPRIYA
Exchange
NSE · BSE
CIN
ISIN
INE07RO01027
BSE code
543434
Sector
Healthcare
Industry
Healthcare
Face value
₹2
Listing date
27 Dec 2021
Employees
Headquarters
Mumbai, India

07 · About

What is Supriya Lifescience Limited?

Supriya Lifescience Limited engages in the research and development, manufacture, and sale of bulk drugs and pharmaceutical chemicals worldwide. The company offers active pharmaceuticals ingredients in antihistamine, anti-allergic, anti-asthmatic, decongestant, analgesic/anti-pyretic/anesthetic, anti–hypertensive, vitamins, anti-malarial, and anti-gout areas. It also provides oncology, veterinary, and general category products. In addition, the company offers GelHeal, a wound care solution; and Quickblue, an oral cancer detection kit. Further, it is developing drugs in the areas of anti-depressant, anti-inflammatory, contrast media, hormones, antibiotic, smoking cessation, anti-diabetic/obesity, anti-ataxia, decongestant, veterinary API, anti-cancer, allogeneic hematopoietic stem cell transplantation, and anti-migraine. Supriya Lifescience Limited was founded in 1987 and is headquartered in Mumbai, India.

08 · Common questions

Frequently asked

What is the CIN of Supriya Lifescience Limited?+

The Corporate Identity Number for Supriya Lifescience Limited is published in the MCA21 corporate master. FinanceCity backfills CIN values during weekly refreshes.

Who are the promoters of Supriya Lifescience Limited?+

Promoter holding in SUPRIYA is approximately 68.30%, as disclosed in the latest published shareholding pattern.

What is the market capitalisation of Supriya Lifescience Limited?+

Supriya Lifescience Limited (SUPRIYA) has a market capitalisation of approximately ₹7579 Cr, reflecting the most recent weekly refresh from the BSE scrip master.

09 · Adjacent

Other healthcare listings

Full sector →